The Allstate Corporation (NYSE:ALL – Get Free Report) insider John Dugenske sold 32,996 shares of the company’s stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $269.33, for a total transaction of $8,886,812.68. Following the completion of the sale, the insider directly owned 13,054 shares of the company’s stock, valued at $3,515,833.82. This represents a 71.65% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link.
Allstate Price Performance
Shares of ALL stock opened at $261.94 on Wednesday. The company has a debt-to-equity ratio of 0.24, a current ratio of 0.36 and a quick ratio of 0.36. The company has a market capitalization of $66.23 billion, a PE ratio of 5.23, a price-to-earnings-growth ratio of 0.44 and a beta of 0.16. The firm’s 50-day moving average is $243.78 and its two-hundred day moving average is $221.66. The Allstate Corporation has a 12 month low of $188.08 and a 12 month high of $277.22.
Allstate (NYSE:ALL – Get Free Report) last posted its quarterly earnings results on Wednesday, August 5th. The insurance provider reported $8.99 earnings per share for the quarter, beating the consensus estimate of $6.06 by $2.93. The business had revenue of $15.43 billion during the quarter, compared to analysts’ expectations of $15.46 billion. Allstate had a net margin of 18.97% and a return on equity of 41.64%. The business’s revenue for the quarter was up 11.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $5.94 EPS. Analysts predict that The Allstate Corporation will post 31.93 earnings per share for the current year.
Allstate Dividend Announcement
Key Headlines Impacting Allstate
Here are the key news stories impacting Allstate this week:
- Positive Sentiment: JPMorgan raised its price target for Allstate from $282 to $292 and maintained an “overweight” rating, implying meaningful upside based on its current valuation. Benzinga report
- Positive Sentiment: Piper Sandler also increased its price target, lifting it from $268 to $300 and reiterating an “overweight” rating. The revision suggests the firm expects continued earnings strength or improved valuation support. Ticker Report article
- Neutral Sentiment: Allstate is preparing its Allie platform as part of an agentic artificial-intelligence strategy. The initiative could improve productivity and customer service over time, although its financial impact remains uncertain. Allstate preps Allie platform to drive agentic AI strategy
- Negative Sentiment: Citi downgraded Allstate to “sell”, arguing that the insurer’s recent operating returns appear “unsustainable.” The call challenges the durability of the company’s recent profit performance. Allstate cut to sell at Citi
- Negative Sentiment: Insider John E. Dugenske sold 32,996 shares worth approximately $8.9 million, reducing his position by about 72%. While insider sales can be planned for personal reasons, the size of the transaction may weigh on sentiment. SEC insider transaction filing
- Negative Sentiment: DOWLING & PARTN projected FY2028 EPS of $25.50, below the current consensus estimate of $31.40 for the full year. The lower forecast raises concerns about longer-term earnings growth.
Institutional Investors Weigh In On Allstate
A number of hedge funds have recently added to or reduced their stakes in the business. Callan Family Office LLC acquired a new position in shares of Allstate in the second quarter worth $1,825,000. Manhattan West Asset Management LLC acquired a new stake in Allstate in the 2nd quarter valued at about $290,000. Keebeck Wealth Management purchased a new position in shares of Allstate in the 2nd quarter valued at about $598,000. Keating Financial Advisory Services Inc. acquired a new position in shares of Allstate during the second quarter worth about $349,000. Finally, OneAscent Financial Services LLC acquired a new position in shares of Allstate during the second quarter worth about $439,000. 76.47% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
ALL has been the topic of a number of recent analyst reports. Mizuho upped their target price on shares of Allstate from $255.00 to $272.00 and gave the company an “outperform” rating in a research report on Thursday, July 9th. Keefe, Bruyette & Woods upped their price objective on shares of Allstate from $242.00 to $255.00 and gave the stock a “market perform” rating in a report on Wednesday, July 8th. Raymond James Financial reaffirmed a “strong-buy” rating and set a $315.00 price objective on shares of Allstate in a research report on Tuesday. Wall Street Zen raised Allstate from a “hold” rating to a “buy” rating in a research report on Monday, July 20th. Finally, Morgan Stanley set a $265.00 price target on Allstate in a research report on Tuesday. Three research analysts have rated the stock with a Strong Buy rating, five have given a Buy rating, ten have issued a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $265.53.
View Our Latest Analysis on Allstate
About Allstate
Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.
The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.
See Also
- Five stocks we like better than Allstate
- Atlassian Just Pulled Off the Software Comeback Wall Street Wanted
- AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be
- NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
- Apple’s Next iPhone Could Test How Much Pricing Power Is Left
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
